QQ客服 官方微博 反馈留言

	DRm217 attenuates myocardial ischemia-reperfusion injury via stabilizing plasma membrane Na+-K+-ATPase, inhibiting Na+-K+-ATPase/ROS pathway and activating PI3K/Akt and ERK1/2
	Yan, Xiaofei; Xun, Meng; Wu, Litao; Du, Xiaojuan; Zhang, Fujun; Zheng, J.
刊名	TOXICOLOGY AND APPLIED PHARMACOLOGY
	2018
卷号	349页码:62-71
关键词	Na+-K+-ATPase Ischemia-reperfusion (IR) Src DRm217 Myocardial cells ROS
ISSN号	0041-008X
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2923097
专题	西安交通大学
推荐引用方式 GB/T 7714	Yan, Xiaofei,Xun, Meng,Wu, Litao,et al. DRm217 attenuates myocardial ischemia-reperfusion injury via stabilizing plasma membrane Na+-K+-ATPase, inhibiting Na+-K+-ATPase/ROS pathway and activating PI3K/Akt and ERK1/2[J]. TOXICOLOGY AND APPLIED PHARMACOLOGY,2018,349:62-71.
APA	Yan, Xiaofei,Xun, Meng,Wu, Litao,Du, Xiaojuan,Zhang, Fujun,&Zheng, J..(2018).DRm217 attenuates myocardial ischemia-reperfusion injury via stabilizing plasma membrane Na+-K+-ATPase, inhibiting Na+-K+-ATPase/ROS pathway and activating PI3K/Akt and ERK1/2.TOXICOLOGY AND APPLIED PHARMACOLOGY,349,62-71.
MLA	Yan, Xiaofei,et al."DRm217 attenuates myocardial ischemia-reperfusion injury via stabilizing plasma membrane Na+-K+-ATPase, inhibiting Na+-K+-ATPase/ROS pathway and activating PI3K/Akt and ERK1/2".TOXICOLOGY AND APPLIED PHARMACOLOGY 349(2018):62-71.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。